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508 The Journal of Thoracic and Cardbjective: There is a need for fast sutureless implantation of valve prostheses with
better outcome than that of current valved stents.
ethods: The suture ring of a St Jude mechanical valve prosthesis (St Jude Medical,
inneapolis, Minn) was replaced by a proprietary non–stent-based attachment ring
ade of Nitinol memory metal (Endosmart, Stutensee, Germany) and covered with
extile. In acute pig experiments, the aortic valve was removed and the device was
ntroduced in a temporary stretched shape and activated by removing constrainers
nd heating to reach its final attachment shape.
esults: The devices could be actuated within seconds. Echocardiography
howed normal prosthetic valve and heart function. No paradevice leakage was
emonstrated by supravalvular angiography. At autopsy, no abnormalities were
ound in the surrounding structures or valve prostheses. Pulling tests showed the
trong adhesive power of Nitinol attachment rings withstanding up to 5 kg of
ulling force.
onclusion: Nitinol memory metal attachment rings, covered with textile, around
uture ring-denuded St Jude mechanical aortic valve prostheses enabled fast and
trong sutureless implantation in acute pig experiments. Further studies in chronic
nimal models and humans are needed to determine long-term safety.
and-suturing is the current standard of attaching a valve prosthesis to the
anatomic valve annulus. However, it is time-consuming, particularly in
multivalve and combined procedures, and makes minimally invasive valve
urgery less favorable. Currently, there is renewed interest in sutureless valve
mplantation, primarily by mounting a biologic aortic valve into a metal stent and
ompressing it into a catheter sleeve.1-3 However, with this technique the diseased
alve is not removed, and current valved stents do not result in outcomes compa-
able to those of surgically removed and replaced heart valves.4 Our intention was
o test the feasibility of a sutureless Nitinol (Endosmart, Stutensee, Germany)
ttachment device that can be combined with any current suture ring-denuded valve
rosthesis, regardless of the position in the heart and type of prosthesis, and that can
ttach the valve prosthesis to the anatomic valve annulus as solidly as current state
f the art hand-suturing. Because durability is an important feature of most available
ood and Drug Administration-approved valve prostheses, our intention was not to
esign a completely new heart valve prosthesis.
aterials and Methods
evices
he suture ring from standard 21-mm St Jude mechanical valve prostheses (St Jude Medical,
inneapolis, Minn) was removed and replaced by a valve attachment ring (VAR) made of
itinol memory metal (Figures 1 and 2). This proprietary ring was sinusoidally shaped to
atch the aortic annulus, with a flexible upper and lower flange. The VAR was fixed around
iovascular Surgery ● December 2007
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EThe carbon housing of the bare valve prosthesis, while maintaining
ts full rotatability. The flanges were composed of separate finger
ows that were temporarily stretched to facilitate passage of the
evice through the aorta and annulus. The ring was maintained in
emporary shape by a low temperature and constraining devices,
uch as a tube or sutures around the fingers and their textile. If the
ing was at its desired position, the fingers were activated to
xpand radially to fit the annulus between them. Actuation of the
etal flanges was done by removing the constraining tools and
eating. Initially the rings were used without any textile covering.
owever, to exclude paradevice leakage and facilitate suture con-
training, a textile covering was necessary, as was done by the first
uthor. The development of the VAR started in 1998, and 6
enerations of prototypes have been manufactured and tested from
001 on. Initially the VAR was placed first and then the valve
rosthesis was connected to it, but an integrated 1-shot device
roved more efficient. The configuration and force of the flange
ngers of the VAR went through a number of iterative improve-
ents. The outer diameter of the device as tested and described
as approximately 20 mm in stretched cold shape (Figure 1, A)
nd approximately 24 mm in expanded warm shape (Figure 1, B),
hereas the height was approximately 12 mm in stretched cold
tate (Figure 2, A) and approximately 10 mm in expanded warm
hape (Figure 2, B). The textile covering of the particular third-
eneration device as used in the described acute experiments was
edundant, which was corrected in later prototypes and
xperiments.
pplicators
our generations of specific applicators to hold, constrain, navi-
ate, and fire the devices were manufactured (Kiki Ingenieursge-
ellschaft, Malsch, Germany). The last-generation applicator con-
isted of 2 arms to hold and release the device, a temporary
onstraining tube with a tapered end that could be moved up and
own to facilitate the introduction of the device, and a hollow
hannel with perforations at the tip of the applicator for free flow
f hot or cold solution as a temperature regulator.
esting
ll prototypes of rings and applicators were tested extensively in
x vivo slaughterhouse pig hearts. As part of these ex vivo tests,
Abbreviations and Acronyms
VAR valve attachment ringThe Journal of Thoraciculling tests with a pulling force measurement device (Force
auge, Lutron, Taipei, Taiwan) were performed in both directions
o determine detachment forces. Starting in 2001, 11 acute in vivo
ig experiments were performed in 3 different animal laboratories:
ierenlaboratorium Leids Universitair Centrum (LUMC, Leiden,
he Netherlands), Animal Laboratory of the Brigham and Wom-
n’s Hospital (Harvard, Boston, Mass), and Laboratorium voor
xperimentele Cardiale Heelkunde (UZG, Gent, Belgium). In all
xperiments the animals received human care in compliance with
he European Convention on Animal Care and the “Guide for the
are and Use of Laboratory Animals,” as published by the US
ational Institutes of Health (Publication No. 85-23, revised
996). All experiments were approved and performed in accor-
ance with the Animal Research Ethics regulation of the institution
nd country where the experiments took place. The last 3 consec-
tive in vivo experiments, as performed in the Laboratorium voor
xperimentele Cardiale Heelkunde, are described in detail.
urgical Procedures
he VAR-valve device was prepared before the procedure. The
anges were manually stretched in ice water, and the device was
laced on the applicator without a constraining tube. Sutures were
xed around the stretched textile-covered rows of the upper and
ower fingers and attached proximally to the applicator.
In anesthetized and ventilated female pigs (weighing 65–85
g), a median sternotomy was performed. After heparinization, the
nimal was placed on full bypass with arterial cannulation in the
scending aorta and venous cannulation in the right atrium. Left
entricular decompression was achieved, the aorta was cross-
lamped, and cold St Thomas’ crystalloid cardioplegia solution
as administered. The aorta was completely transected a few
illimeters above the valve commissures, which were retracted
ith sutures. The aortic valve was completely removed. A circular
nnular suture (2-0 Excel, Ethicon, Somerville, NJ) was placed in
rather flat plane following the aortic annulus, but below the
ommissures, to compensate for mismatch between the diameters
f the annulus and the VAR; there was only 1 size of prototype
vailable, and the porcine annulus diameter was variable and
exible in young pigs. Three mattress sutures with pledget (2-0
xcel, Ethicon) were placed in the middle of the sinuses and
utured through the textile covering of the upper row of fingers to
uide the VAR to its desired position, because direct view in the
elative small aorta was obliterated by the device and applicator.
hile the guiding sutures were pulled, the VAR valve was intro-
uced into the aorta and positioned at the annular level. The
onstraining sutures that kept the flanges in temporary stretched
osition were cut and retracted, and the applicator was removed.
Figure 1. A, Textile-covered third-generation de-
vice in stretched cold shape from below. B,
Textile-covered third-generation device in ex-
panded warm shape from below.and Cardiovascular Surgery ● Volume 134, Number 6 1509
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1
EThe 3 guiding sutures and the circular annular suture were tied. In
hese particular cases, no use was made of the fluid holes in the
pplicator, but the VAR was actuated with warm (45°C) physio-
ogic salt solution that was poured in the pericardium. The aorta
as closed, and the animal was weaned from bypass. A calculated
ose of protamine was given.
Heart and valve function were evaluated and registered by
ransesophageal echocardiography before bypass, before weaning
rom bypass, and after bypass. After bypass, the heart was allowed
o beat for another 2 to 3 hours. During this time a supravalvular
ngiography was performed. After this time, the animals were
illed, and the heart with the ascending aorta was taken out for
ross examination. The position and function of the VAR valve
ere determined. Paravalvular leakage was sought using 1-mm
robes. Inspection for damages of surrounding structures included
emoval of the device.
esults
n ex vivo pig heart experiments, it was demonstrated that
AR valves actuated at the aortic annulus in the described
ashion could withstand up to 5 kg (the maximum of the
sed force gauge) of pulling force in the direction of the
scending aorta and left ventricle. In the last 3 consecutive
n vivo experiments, the VAR valves were successfully
ntroduced into the aorta, navigated to the annulus, and
ctuated. Most of the operating time was consumed by
losing the ascending aorta, which needed to be transected
o enhance exposure. If we define valve replacement time asFigure 3. Valve replacemen
510 The Journal of Thoracic and Cardiovascular Surgery ● Deche time between the removal of the valve and the closure of
he aorta, we observed a 50% reduction of this time with
urther experience, which was 12 minutes in our last exper-
ment (Figure 3). The time necessary for navigation and
ctuation of the device was approximately 2 minutes. The
evice actuation itself lasted less than 5 seconds. The rest of
he time was spent on placement and tying the annular and
uiding sutures. All animals were removed from bypass,
ithout inotropic support, and remained hemodynamically
table for several hours until intended termination. There
ere no signs of ischemia or conduction abnormalities.
fter the procedure there were no signs of paradevice
eakage, determined on the basis of diastolic systemic blood
ressure, blood pressure curve, transesophageal echo (Fig-
res 4 and 5), supravalvular angiography (Figure 6), and
ircumference probe of the devices at autopsy. Normal
pening and closing of the valve prosthesis were confirmed
y transesophageal echo, fluoroscopy, supravalvular an-
iography, and postmortem examination (Figures 7 and 8).
n these particular cases, the textile covering was shown to
e redundant; this was corrected in later prototypes. Trans-
sophageal echo revealed no valve gradients, with normal
eart contractility and normal mitral valve function. Flow
elocity over the valve prosthesis was 1.5 m/sec in 2 ex-
eriments and 2.0 m/sec in 1 experiment, which was attrib-
ted to too much textile at the upper side of the VAR; this was
Figure 2. A, Textile-covered third-generation de-
vice in stretched cold shape from aside. B, Tex-
tile-covered third-generation device in ex-
panded warm shape from aside.t time in last 3 cases.
ember 2007
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ETubsequently corrected. Postmortem examination showed a
mall hematoma at the outside and base of the ascending aorta
n some cases, most likely the result of the circular annular
uture. All devices were neatly situated at the aortic annulus,
ith unimpeded coronary ostia and without macroscopic dam-
ge to the mitral valve or other surrounding tissues.
onclusions
he use of Nitinol memory metal attachment rings to implant
echanical aortic valve prostheses in the acute pig model is
ast and feasible. The devices and applicators are relatively
asy to handle. VAR valves were firmly attached to the aortic
nnulus without any aortic insufficiency or stenosis. One can
rgue that the study was performed in pigs with healthy aortic
alves, whereas the devices eventually will be used for dis-
ased calcified aortic valves. However, we are not aware of a
ig model with calcified aortic valves, and our philosophy
emains that the complete removal of all diseased valve tissue
n patients will lead to better results than leaving it behind. It
as been reported that it is difficult to fix valved stents to the
ortic valve annulus in healthy animals. In healthy pigs, it has
igure 4. Echogram device in situ during systole. Opened valve
lade (arrow).
igure 5. Echogram device in situ during diastole. Closed valve
Klade (arrow).
The Journal of Thoraciceen reported that only 67% of valved stents introduced
hrough the left ventricular apex were deployed successfully,
hereas 78% of deployed valved stents showed some degree
f paravalvular leakage.5 In one third of the cases the valved
tents migrated back into the left ventricle or distally into the
scending aorta.5 In healthy sheep, Eltchaninoff and col-
eagues6 decided to deploy valved stents in the descending
orta because the lack of calcium and elasticity in the sheep’s
ortic root can easily lead to valve migration or death. One can
rgue that we still used some sutures during implantation.
owever, these sutures were not essential for VAR-valve
ttachment. The circular annular suture was used to compen-
ate for prosthetic–annular mismatch, because the diameter of
he annulus varied and the annulus was flexible in the young
igs, and only 1 size VAR-valve prototype was available. The
guiding sutures were only used to guide the device to its
esired destination and were not essential for fixation of the
evice. The ascending aorta of a pig is so small that after
ntroduction of the device and applicator, direct view of the
nnulus is hindered. In surgically used valved stents in hu-
ans, such as the Enable valve (3F, ATS Medical Inc, Min-
eapolis, Minn), similar guiding sutures are used.7 Further
tudies in the chronic animal model, and eventually in the
linical human setting, are necessary to demonstrate the feasi-
ility and safety of the VAR devices and method in patients.
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